George A Cross

Title: Innovations of George A Cross in Recombinant DNA Technology

Introduction

George A Cross is a notable inventor based in Biggin Hill, GB. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technology. His work has implications for vaccine development, specifically targeting foot and mouth disease.

Latest Patents

One of George A Cross's key patents is titled "Recombinant DNA expression vector encoding for foot and mouth disease." This patent describes a DNA molecule that comprises a nucleotide sequence substantially corresponding to all or a portion of foot and mouth disease virus RNA. It specifically codes for at least one protein of the foot and mouth disease virus. The DNA molecule can be inserted into a DNA cloning vehicle capable of expressing the DNA molecule after a suitable host cell has been transformed by the cloning vehicle. The expression product can be incorporated into a vaccine for stimulating antibodies against FMDV. The patent also outlines methods for producing the DNA molecule, recombinant cloning vehicle, and transformed host cell.

Career Highlights

Throughout his career, George A Cross has focused on innovations that enhance the understanding and treatment of viral diseases. His work has been instrumental in advancing the field of molecular biology and vaccine development.

Collaborations

George A Cross has collaborated with notable colleagues, including Michael D Winther and Fred C Brown. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

George A Cross's contributions to recombinant DNA technology and vaccine development highlight his role as an influential inventor in the biotechnology sector. His work continues to impact the fight against viral diseases, showcasing the importance of innovation in science.